483
Gilead Sciences, Inc.FDA 483 - Gilead Sciences, Inc. - July 17, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Gilead Sciences, Inc. in Foster City, CA, was inspected regarding its drug safety and public health practices. The inspection revealed a significant failure to report serious and unexpected adverse drug experiences to the FDA within the required 15 calendar days. This indicates a lapse in pharmacovigilance and regulatory compliance.
Open in Dashboard
ID · 6e644d94-ebcd-4830-b63d-611baa563e49